How do I warm HPC(A) products to maximize cell viability in the setting of cold agglutinin disease?

These results can inform decisions to improve patient care and minimize product manipulation and loss. Centers are encouraged to use this information to guide proactive measures to establish a standard operating procedure to manage CAD cases.